RE:RE: UNITED KINGDOM...now...DENMARK?!?Thanks Ed. The only other CBD masterfile is held by EPIDIOLEX Maker GW/JAZZ....EPIDIOLEX is the only FDA approved cannabinoid drug in the U.S.A..as it stands the only corporation able to supply API for a generic is LABS...this is one of the many ambitions LABS has been working towards over many years and the finish line is near. Next step is API supply deal or Generic (go it alone) release. Distribution will be difficult so I'd prefer partnership with big pharma. Third option is a buyout from JAZZ, Medipharm is the only present threat to this highly profitable 900m usd revenue stream whom's market cap is a measly 16m usd..this one opportunity alone gives MEDIPHARM a significantly higher value then presently afforded and I believe it's been completely, grossly overlooked by analysts and market participants...